Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.23
0.0000
Volume:2.37M
Turnover:2.96M
Market Cap:276.42M
PE:-1.26
High:1.28
Open:1.22
Low:1.21
Close:1.23
52wk High:3.78
52wk Low:0.8621
Shares:224.73M
Float Shares:168.00M
Volume Ratio:1.02
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9781
EPS(LYR):-1.3222
ROE:-54.43%
ROA:-27.34%
PB:0.88
PE(LYR):-0.93

Loading ...

Jun 16, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 15, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report
May 19, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 15, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 26, 2020

Major Issues Report

8-K/A [Amend] - Current report
Aug 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]